Weight loss medications like Ozempic and Wegovy are doing more than shrinking waistlines—they’re transforming how people date and connect romantically.
A new survey from the Kinsey Institute reveals that 59% of GLP-1 users report significant changes in their dating lives, with men experiencing particularly dramatic shifts in confidence and romantic success.
The nationally representative study of 2,000 single U.S. adults found that 8% had used GLP-1 medications for weight loss, with no significant difference between men and women. However, the drugs’ impact on dating behavior varied considerably by gender, suggesting these medications are reshaping modern romance in unexpected ways.
Dating Confidence Gets a Chemical Boost
The survey revealed substantial changes in dating behavior among GLP-1 users. Nearly one in five (17%) purchased new clothing to show off their transformed bodies, while 16% reported hearing from exes wanting to reconnect. Perhaps most tellingly, 14% said they were getting more matches on dating apps.
“GLP-1 use is rising among single adults and it’s starting to influence more than just how people look and feel about themselves,” says Dr. Amanda Gesselman, Research Scientist at the Kinsey Institute and one of the study’s authors. “These shifts have the potential to reshape how people build intimacy in today’s dating landscape.”
The medication’s effects extend beyond physical appearance. Users reported increased willingness to put themselves out there romantically, with 13% feeling more confident posting photos online and 12% more willing to ask others out.
Gender Differences Tell a Complex Story
Men appeared to experience more dramatic dating improvements than women. The survey found men were three times more likely to report feeling more confident in their appearance and twice as likely to say they were going on more dates. They also showed greater success on dating platforms, with men significantly more likely to report increased matches.
Key gender differences included:
- Men were twice as likely to report going on more dates
- Men showed three times higher rates of appearance confidence
- Men experienced more dramatic swings in sexual function—both positive and negative
- Men reported higher anxiety about being judged for using the medication
“These results suggest that GLP-1 medications are giving men a bigger boost in their dating lives than women,” notes Dr. Justin Lehmiller, Senior Research Fellow at the Kinsey Institute and study co-author.
Sexual Health Shows Mixed Results
The drugs’ impact on sexual satisfaction proved more complex. Approximately 52% of users reported changes in their sex lives, with effects varying dramatically between individuals. While 18% experienced increased sexual desire, 16% reported decreased libido. Similarly, 16% said their sexual function improved, while 12% reported worsening performance.
Lehmiller explains the variability: “How these drugs impact your sex life will depend on a variety of factors, including drug dosage and drug type, speed of weight loss, starting and ending weight, and how much you changed your health and fitness habits at the same time.”
Men again showed more extreme responses, being twice as likely as women to report both improved and worsened sexual function. This pattern suggests the medications may amplify existing tendencies rather than creating uniform effects.
Social Stigma and Masculinity Concerns
Despite positive dating outcomes, many users—particularly men—worried about social judgment. The survey found 60% of men feared being judged for taking GLP-1 medications, compared to just 35% of women. This disparity may reflect broader cultural attitudes about masculinity and weight loss assistance.
The research highlights how these widely-used medications are creating ripple effects throughout modern dating culture. As usage rates potentially reach 12% of the adult population, according to some polls, understanding these social and psychological impacts becomes increasingly important for both users and healthcare providers.
The study suggests that as GLP-1 use continues growing, dating norms may continue evolving, potentially moving away from traditional dinner-and-drinks dates as users report reduced appetites and lower interest in alcohol.
ScienceBlog.com has no paywalls, no sponsored content, and no agenda beyond getting the science right. Every story here is written to inform, not to impress an advertiser or push a point of view.
Good science journalism takes time — reading the papers, checking the claims, finding researchers who can put findings in context. We do that work because we think it matters.
If you find this site useful, consider supporting it with a donation. Even a few dollars a month helps keep the coverage independent and free for everyone.